Health ❯Public Health ❯Vaccination ❯COVID-19 Vaccines

FDA Policies

FDA Expands Myocarditis Warnings for COVID-19 Vaccines Amid Senate Scrutiny

New labels highlight rare heart risks for young males as a Senate report alleges delays in public warnings by health agencies.

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups